KRas G12C inhibitor 3
- CAS NO.：2206735-75-1
- Empirical Formula: C32H36ClN7O2
- Molecular Weight: 586.13
- MDL number: MFCD31692391
- Update Date: 2026-05-11 16:31:51
What is KRas G12C inhibitor 3?
Description
KRas G12C inhibitor 3 is a compound that inhibits KRas G12C, extracted from patent US 20180072723 A1.
References
[1]. Blake J, et al. Kras g12c inhibitors. US 20180072723 A1.
Properties of KRas G12C inhibitor 3
| Boiling point: | 856.7±75.0 °C(Predicted) |
| Density | 1.271±0.06 g/cm3(Predicted) |
| storage temp. | Store at -20°C |
| solubility | Soluble in DMSO |
| pka | 9.31±0.40(Predicted) |
Safety information for KRas G12C inhibitor 3
Computed Descriptors for KRas G12C inhibitor 3
New Products
Cis-Tosylate 1,2,3,9-Tetrahydro-9-Methyl-4H-Carbazole-4-One Dibenzo[b,f][1,4]thiazepin-11(10H)-one Dibenzoyl-L-tartaric acid Anhydrous (Resolution Reagent) N-BOC-piperidine-4-carboxylic acid 1-Benzhydrylazetane-3-carbonitrile AMINO-(3-CHLORO-PHENYL)-ACETIC ACID 2-(2-Chlorophenyl)glycine (±)-amino(2-fluorophenyl)acetic acid 8-oxa-1,3-diazaspiro[4.5]decane-2,4-dione BENZOIC ACID-D METHANE SULFONIC ACID-D4 PHOSPORIC ACID-D3 85 W% IN D2O DEUTERIUM OXIDE FOR NMR TOLUENE-D3 BENZENE-D6 1-Acetyl-4-(4-hydroxyphenyl)piperazine 1-(3-Chlorophenyl)piperazine hydrochlorideYou may like
-
7292-71-9 AMINO-(3-CHLORO-PHENYL)-ACETIC ACID 98+View Details
7292-71-9 -
84145-28-8 98+View Details
84145-28-8 -
2-(2-Chlorophenyl)glycine 98+View Details
88744-36-9 -
8-oxa-1,3-diazaspiro[4.5]decane-2,4-dione 39124-19-1 98+View Details
39124-19-1 -
7292-71-9 AMINO-(3-CHLORO-PHENYL)-ACETIC ACID 98+View Details
7292-71-9 -
84145-28-8 98+View Details
84145-28-8 -
2-(2-Chlorophenyl)glycine 98+View Details
88744-36-9 -
8-oxa-1,3-diazaspiro[4.5]decane-2,4-dione 39124-19-1 98+View Details
39124-19-1
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.